Destiny Pharma is a clinical stage biotechnology company focused on the development of novel medicines to prevent life threatening infections.
The Company is developing novel antimicrobial drugs from its “in-house” XF platform and also from recently acquired Biotherapeutic products that harness beneficial components of the human microbiome. We have two exciting late stage clinical assets and a range of earlier research programmes.
Its pipeline has novel microbiome-based biotherapeutics and XF drug clinical assets including NTCD-M3, a Phase 3 ready treatment for the prevention of C. difficile infection (CDI) recurrence which is the leading cause of hospital acquired infection in the US and also XF-73 nasal gel, which has recently completed a positive Phase 2b clinical trial targeting the prevention of post-surgical staphylococcal hospital infections including MRSA. It is also co-developing SporCov, a novel, biotherapeutic product for the prevention of COVID-19 and other viral respiratory infections and has earlier grant funded XF research projects.
The net proceeds of the Fundraising will allow the Company to continue progress towards Phase 3 trials in its two lead, clinical assets, NTCD-M3 and XF-73 Nasal, and finalise regulatory plans, whilst also strengthening the balance sheet as the Company progresses partnering discussions in relation to NTCD-M3.
This encouraging research programme stems from a collaboration Destiny Pharma has with SporeGen Limited
Calculus VCT has invested into Destiny Pharma, a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention.
WorkL is the home of the World’s Happiest Workplace List and the UK’s largest job marketplace
Harnessing the power of multiomics to transform genomic medicine
MIP Discovery is a novel affinity reagent company, commercialising various forms of Molecularly Imprinted Polymers.
Hinterview is an award-winning video platform for the recruitment sector.
Mo is an employee engagement platform, helping people build a more meaningful relationship with work
Laverock is a Gene Editing induced Gene Silencing platform.
Arctic Shores is leading the way to help employers build the diverse, successful workforce of tomorrow.
Optalitix adds value to insurers, and other financial institutions, with low code SaaS products, data analysis and sophisticated AI models.
Notify is a provider of digital workplace safety, wellbeing, environmental and governance compliance services.
Film and television production company founded by BAFTA winning and Academy Award nominated Jude Law.
Brouhaha is a production company with an extensive slate of projects.
Spectral has a 'DeepView' wound imaging system, aims to improve the accuracy and speed at which damaged tissue is identified and treated.
Invizius is a biotechnology company developing treatments to suppress unwanted innate immune responses
eConsult Health is the leading online consultation provider to the NHS for primary care
Arecor is a life sciences company focused on developing superior biopharmaceutical products via the application of its patented Arestat™ formulation technology platform
Censo Biotechnologies (Axol Bioscience) supply high quality adult human cells, especially live human neurons, created by stem cell technology, to many of the world’s biggest and best-known pharma companies and research institutions.
Home Team is a new TV and film production company
Maven is a leading media and entertainment development and production company, founded by experienced producers Celine Rattray and Trudie Styler.
Wazoku is an idea management company providing a customisable off-the-shelf platform to enterprise customers to manage innovation within an organisation
Rotageek uses cloud-based technology and automatic scheduling to help multi-site businesses manage and schedule staff
Essentia Analytics, a FinTech company, applying behavioural analytics to help professional asset managers make measurably better decisions
A UK-based production company co-founded by Oscar-winning actor Colin Firth and music industry veteran Ged Doherty
Evoterra brings traditional and renewable energy under one umbrella.
IPV provides digital asset management software to the global broadcast industry
A world leading provider of forensic financial solutions and services to protect organisational spend.
Wonderhood is the creative business founded by former Channel 4 CEO David Abraham and senior partners from the TV production and advertising sectors.
Quai Administration Services Limited is a digital administration company which provides an integrated, simplified administration platform for the high-volume personal savings industry.
Blu Wireless provides the technology required for microchips to process data at very high frequencies, for use in the roll-out of WiGig and 5G networks.
C4X Discovery is a drug discovery and development company
Oxford BioTherapeutics is a clinical stage oncology company committed to the discovery and development of novel therapies for various cancer types.
Weedingtech is a cleantech company focused on replacing toxic herbicides
Open Energy Market (‘OEM’), is an online trading platform for energy contracts for medium-large enterprises.
WheelRight provide real-time tyre diagnostics to enable tyre safety management, performance assessment and defect enforcement to commercial transport and logistics fleets, government inspection and standards agencies and the general travelling public.
Scancell is developing novel immunotherapies for the treatment of cancer based on its ImmunoBody and Moditope technology platforms